Lighthouse Pharma Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Employees
  • 12

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $15.2M

  • Investors
  • 4

Lighthouse Pharma General Information

Description

Developer of a precision medicine designed to target Alzheimer's and other diseases with unmet medical needs. The company is developing novel, potent, and selective protease inhibitors based on precision medicine for chronic degenerative and inflammatory disorders, enabling healthcare providers and patients to solve dementia, periodontal disease, atherosclerosis, and orodigestive cancers.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 8001 Redwood Boulevard
  • Novato, CA 94945
  • United States
+1 (650)
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Vertical(s)
Corporate Office
  • 8001 Redwood Boulevard
  • Novato, CA 94945
  • United States
+1 (650)

Lighthouse Pharma Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Lighthouse Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC (Series A) 06-May-2026 $15.2M Completed Clinical Trials - Phase 2
2. Grant 22-Aug-2025 Completed Clinical Trials - Phase 2
1. Early Stage VC (Series A) 01-Dec-2023 $2.75M $2.75M Completed Clinical Trials - Phase 2
To view Lighthouse Pharma’s complete valuation and funding history, request access »

Lighthouse Pharma Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A
Series A-1
To view Lighthouse Pharma’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Lighthouse Pharma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Lighthouse Pharma Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Double Point Ventures Venture Capital Minority
Marin Sonoma Impact Ventures Venture Capital Minority
National Institute on Aging Government
Portfolia Venture Capital Minority
To view Lighthouse Pharma’s complete investors history, request access »

Lighthouse Pharma Investments (1)

Lighthouse Pharma’s most recent deal was a Corporate Asset Purchase with Quince Therapeutics (Legacy Small Molecule Protease Inhibitor Portfolio in California) for . The deal was made on 27-Jan-2023.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Quince Therapeutics (Legacy Small Molecule Protease Inhibitor Portfolio in California) 27-Jan-2023 Corporate Asset Purchase Buildings and Property
To view Lighthouse Pharma’s complete investments history, request access »

Lighthouse Pharma FAQs

  • When was Lighthouse Pharma founded?

    Lighthouse Pharma was founded in 2022.

  • Where is Lighthouse Pharma headquartered?

    Lighthouse Pharma is headquartered in Novato, CA.

  • What is the size of Lighthouse Pharma?

    Lighthouse Pharma has 12 total employees.

  • What industry is Lighthouse Pharma in?

    Lighthouse Pharma’s primary industry is Drug Discovery.

  • Is Lighthouse Pharma a private or public company?

    Lighthouse Pharma is a Private company.

  • What is the current valuation of Lighthouse Pharma?

    The current valuation of Lighthouse Pharma is .

  • What is Lighthouse Pharma’s current revenue?

    The current revenue for Lighthouse Pharma is .

  • How much funding has Lighthouse Pharma raised over time?

    Lighthouse Pharma has raised $18M.

  • Who are Lighthouse Pharma’s investors?

    Double Point Ventures, Marin Sonoma Impact Ventures, National Institute on Aging, and Portfolia have invested in Lighthouse Pharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process